HomeBusiness & MoneyUnicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 (NASDAQ:UNCY)

Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 (NASDAQ:UNCY)


  • Unicycive Therapeutics press release (UNCY): Q3 GAAP EPS of -$0.46 beats by $0.07.
  • As of September 30, 2025, cash and cash equivalents totaled $42.7 million. The Company believes that it has a cash runway into 2027.



Source link

RELATED ARTICLES

Most Popular

Recent Comments